227 related articles for article (PubMed ID: 30753603)
1. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
[TBL] [Abstract][Full Text] [Related]
2. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
3. The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation.
Zhang H; Gao M; Zhao W; Yu L
Breast Cancer Res; 2023 Oct; 25(1):129. PubMed ID: 37885030
[TBL] [Abstract][Full Text] [Related]
4. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
5. Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness.
Emdad L; Janjic A; Alzubi MA; Hu B; Santhekadur PK; Menezes ME; Shen XN; Das SK; Sarkar D; Fisher PB
Neuro Oncol; 2015 Mar; 17(3):419-29. PubMed ID: 25216670
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling.
Chen B; Wang M; Qiu J; Liao K; Zhang W; Lv Q; Ma C; Qian Z; Shi Z; Liang R; Lin Y; Ye J; Qiu Y; Lin Y
J Exp Clin Cancer Res; 2022 Jun; 41(1):209. PubMed ID: 35765111
[TBL] [Abstract][Full Text] [Related]
7. GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription.
Zhang S; Gao M; Yu L
Cancer Med; 2019 Sep; 8(11):5242-5253. PubMed ID: 31286678
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
[TBL] [Abstract][Full Text] [Related]
9. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract][Full Text] [Related]
10. S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis.
Wang H; Yin M; Ye L; Gao P; Mao X; Tian X; Xu Z; Dai X; Cheng H
Technol Cancer Res Treat; 2021; 20():15330338211011961. PubMed ID: 33902363
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.
Huang RQ; Wang SQ; Zhu QB; Guo SC; Shi DL; Chen F; Fang YC; Chen R; Lu YC
Mol Carcinog; 2019 Jan; 58(1):135-143. PubMed ID: 30255656
[TBL] [Abstract][Full Text] [Related]
13. ACYP2 contributes to malignant progression of glioma through promoting Ca
Li M; Ruan B; Wei J; Yang Q; Chen M; Ji M; Hou P
J Exp Clin Cancer Res; 2020 Jun; 39(1):106. PubMed ID: 32517717
[TBL] [Abstract][Full Text] [Related]
14. Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.
Teng L; Nakada M; Furuyama N; Sabit H; Furuta T; Hayashi Y; Takino T; Dong Y; Sato H; Sai Y; Miyamoto K; Berens ME; Zhao SG; Hamada J
Neuro Oncol; 2013 Dec; 15(12):1710-20. PubMed ID: 24121831
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑940 promotes cell proliferation and invasion of glioma by directly targeting Kruppel‑like factor 9.
Zhang D; Hao P; Jin L; Wang Y; Yan Z; Wu S
Mol Med Rep; 2019 Jan; 19(1):734-742. PubMed ID: 30431124
[TBL] [Abstract][Full Text] [Related]
17. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.
Bian E; Chen X; Xu Y; Ji X; Cheng M; Wang H; Fang Z; Zhao B
J Exp Clin Cancer Res; 2019 Aug; 38(1):366. PubMed ID: 31429770
[TBL] [Abstract][Full Text] [Related]
18. Silencing Drp1 inhibits glioma cells proliferation and invasion by RHOA/ ROCK1 pathway.
Yin M; Lu Q; Liu X; Wang T; Liu Y; Chen L
Biochem Biophys Res Commun; 2016 Sep; 478(2):663-8. PubMed ID: 27495873
[TBL] [Abstract][Full Text] [Related]
19. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I
Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
